ClinicalTrials.Veeva

Menu

UPnRIDE Power Standing Wheelchair for SCI

B

Bronx Veterans Medical Research Foundation, Inc

Status

Completed

Conditions

Spinal Cord Injuries

Treatments

Device: UPnRIDE power wheelchair

Study type

Interventional

Funder types

Other

Identifiers

NCT04163796
SPU-17-036

Details and patient eligibility

About

People with higher level of spinal cord injury have limitations to using exoskeletal-assisted walking devices due to restrictions of trunk stability, functional use of the upper extremities and hand grip. With increasing sedentary time in wheelchairs, people with SCI have a high risk for developing secondary complications. A powered wheelchair has recently been developed for use in persons with spinal cord injury that provides a solution for placing the user in an upright, standing position while maintaining the overground mobility features of the powered wheelchair; providing the ability to engage in society in either a standing or seated position. The purpose of this study is to verify user performances of the upright powered wheelchair and to identify obstacles that are difficult, or prevent use. Additionally, the option to have upright posture throughout the day may have the potential to improve some of the secondary medical conditions associated with the extreme sedentary lifestyle.

This study will determine change from baseline after 12 weeks of use for safety, tolerance, medical, physical and quality of life outcomes. The intervention will consist of 3.5 hours per session, 3 times per week for 12 weeks. During each session, participants will be asked to stand at least 5 minutes during every 15 minutes. To our knowledge, there is no existing empirical data on intermittent standing during the day in persons with higher levels of SCI who cannot otherwise stand and whether this approach will improve health related outcomes.

Enrollment

5 patients

Sex

All

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Power wheelchair user as a primary means of mobility;
  2. 18-89 years old;
  3. ≥1 year after SCI;
  4. Height of 160 to 190 cm;
  5. Weight of <100 kg; and
  6. Able to sign informed consent.

Exclusion criteria

  1. Able to ambulate with or without an assistive device or physical assistance greater than 4 consecutive steps;
  2. Any pressure ulcer at any body location that is deemed to be contraindicated for a power wheelchair or standing frame by the study physician;
  3. Concurrent medical disease that would be exclusionary for standing (as per the clinical judgment of the study physician);
  4. Severe spasticity (Ashworth 4) or uncontrolled clonus;
  5. History of fragility fractures, long bone fractures in the past 1 years, heterotrophic ossification, or other bone conditions that would be exclusionary for use of a standing modality as per the clinical judgment of the study physician;
  6. Significant contractures that would be exclusionary for use of a standing modality as per the clinical judgment of the study physician
  7. Psychiatric or cognitive status that may interfere with the ability to follow instruction to use the device; and
  8. Pregnant or lactating women.

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

5 participants in 1 patient group

UPnRIDE Training
Experimental group
Description:
During each session, heart rate (HR), blood pressure (BP), total session time, time in standing posture, count of sit-to-stand positioning, total distance of overground movement, and rating of perceived exertion (Borg scale) for mobility skills will be monitored. At all study visits during the training period, participants will be asked to answer general health questions about the occurrence of any pressure ulcers or infections.
Treatment:
Device: UPnRIDE power wheelchair

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

EunKyoung Hong, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems